Skip to Main Content

Paper Details

mTADA is a framework for identifying risk genes from de novo mutations in multiple traits.
Nat Commun
7
2020
CHD, DNMs, congenital heart disease, epileptic encephalopathies, genes, intellectual disability, mTADA, neuropsychiatric disorders, risk genes, risk-gene, schizophrenia
Author NameAffiliation
Brien P RileyVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University
Joseph D BuxbaumIcahn School of Medicine at Mount Sinai
Joseph D BuxbaumIcahn School of Medicine at Mount Sinai
Dalila PintoIcahn School of Medicine at Mount Sinai
Dalila PintoFriedman Brain Institute, Icahn School of Medicine at Mount Sinai
Dalila PintoThe Mindich Child Health & Development Institute, Icahn School of Medicine at Mount Sinai
Dalila PintoIcahn School of Medicine at Mount Sinai
Dalila PintoThe Mindich Child Health & Development Institute, Icahn School of Medicine at Mount Sinai
Dalila PintoFriedman Brain Institute, Icahn School of Medicine at Mount Sinai
Shaun PurcellBrigham and Women's Hospital, Harvard Medical School
Shaun PurcellBrigham and Women's Hospital, Harvard Medical School
Patrick F SullivanUniversity of North Carolina
Patrick F SullivanUniversity of North Carolina
Xin HeGrossman Institute for Neuroscience, University of Chicago
Xin HeUniversity of Chicago
Eli A StahlInstitute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai
Eli A StahlStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
  • 1 - 17

Datasets